{"data":[{"accessionNo":"0001193125-26-354412","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001802768","issuerName":"Royalty Pharma plc","ticker":"RPRX","cusip":"G7709Q104","securityClass":"Class A ordinary shares, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"Legorreta G. Pablo","reportingCik":"0001507678","personType":"IN","sharesOwned":101785843,"percentOfClass":18.73,"filedAt":"2026-08-17"},{"accessionNo":"0001193125-26-354412","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001802768","issuerName":"Royalty Pharma plc","ticker":"RPRX","cusip":"G7709Q104","securityClass":"Class A ordinary shares, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"Legorreta Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":37535019,"percentOfClass":7.76,"filedAt":"2026-08-17"},{"accessionNo":"0001140361-26-025447","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001802768","issuerName":"Royalty Pharma plc","ticker":"RPRX","cusip":"G7709Q104","securityClass":"Class A Ordinary Shares, par value $0.0001 per share","eventDate":"2026-06-12","reportingPerson":"Butterfield Fiduciary Administrators Trust Company Limited","reportingCik":null,"personType":"CO","sharesOwned":21366927,"percentOfClass":4.8,"filedAt":"2026-06-16"},{"accessionNo":"0001140361-26-025447","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001802768","issuerName":"Royalty Pharma plc","ticker":"RPRX","cusip":"G7709Q104","securityClass":"Class A Ordinary Shares, par value $0.0001 per share","eventDate":"2026-06-12","reportingPerson":"Severgnini Achille G.","reportingCik":"0001814880","personType":"IN","sharesOwned":21366927,"percentOfClass":4.8,"filedAt":"2026-06-16"},{"accessionNo":"0001562230-26-000055","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001802768","issuerName":"Royalty Pharma PLC","ticker":"RPRX","cusip":"G7709Q104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital International Investors","reportingCik":null,"personType":"IA","sharesOwned":37772419,"percentOfClass":8.8,"filedAt":"2026-05-14"},{"accessionNo":"0001140361-26-006327","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001802768","issuerName":"Royalty Pharma plc","ticker":"RPRX","cusip":null,"securityClass":"Class A Ordinary Shares, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"R & H Trust Co. (Guernsey) Limited","reportingCik":null,"personType":"CO","sharesOwned":24223082,"percentOfClass":5.7,"filedAt":"2026-02-20"},{"accessionNo":"0001140361-26-006327","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001802768","issuerName":"Royalty Pharma plc","ticker":"RPRX","cusip":null,"securityClass":"Class A Ordinary Shares, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Severgnini Achille G.","reportingCik":"0001814880","personType":"IN","sharesOwned":24223082,"percentOfClass":5.7,"filedAt":"2026-02-20"},{"accessionNo":"0001562230-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001802768","issuerName":"Royalty Pharma PLC","ticker":"RPRX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Capital International Investors","reportingCik":null,"personType":"IA","sharesOwned":32745526,"percentOfClass":7.7,"filedAt":"2026-02-13"},{"accessionNo":"0001562230-25-000125","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001802768","issuerName":"Royalty Pharma PLC","ticker":"RPRX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Capital International Investors","reportingCik":null,"personType":"IA","sharesOwned":28512128,"percentOfClass":6.6,"filedAt":"2025-11-13"},{"accessionNo":"0000315066-25-002828","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001802768","issuerName":"ROYALTY PHARMA PLC","ticker":"RPRX","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":27900713.73,"percentOfClass":6.5,"filedAt":"2025-11-05"},{"accessionNo":"0000315066-25-002828","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001802768","issuerName":"ROYALTY PHARMA PLC","ticker":"RPRX","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":27900713.73,"percentOfClass":6.5,"filedAt":"2025-11-05"},{"accessionNo":"0000102909-25-000191","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001802768","issuerName":"Royalty Pharma PLC","ticker":"RPRX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":10936538,"percentOfClass":2.52,"filedAt":"2025-10-30"}],"updatedAt":"2026-10-15T08:02:16.770Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}